Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008 and is headquartered in Seattle, WA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
15
Frequently Asked Questions
What is Market Cap of Atossa Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Atossa Therapeutics Inc market cap is $109.63M.
What is the 52-week high for Atossa Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Atossa Therapeutics Inc 52 week high is $1.66 as of September 22, 2025.
What is the 52-week low for Atossa Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Atossa Therapeutics Inc 52 week low is $0.5526 as of September 22, 2025.
What is Atossa Therapeutics Inc stock price today?
Atossa Therapeutics Inc stock price today is $0.8233.
What was Atossa Therapeutics Inc stock price yesterday?
Atossa Therapeutics Inc stock price yesterday was $0.8487.
What is the PE ratio of Atossa Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Atossa Therapeutics Inc’s P/E ratio is -3.78.
What is the Price-to-Book ratio of Atossa Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Atossa Therapeutics Inc P/B ratio is 1.9001.
What is the 50-day moving average of Atossa Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Atossa Therapeutics Inc 50-day moving average is $0.8161.
How many employess does Atossa Therapeutics Inc has?
ATOS Atossa Therapeutics Inc